| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Reuven Yeganeh | Director | 2026-03-17 | 530,000 | $2.00 | $1.06MBuy |
| Reuven Yeganeh | Director | 2026-03-17 | 530,000 | $5.00 | $2.65MSell |
| Reuven Yeganeh | Director | 2026-03-16 | 450,000 | $2.00 | $900.00kBuy |
| Reuven Yeganeh | Director | 2026-03-16 | 450,000 | $5.00 | $2.25MSell |
| Reuven Yeganeh | Director | 2026-03-13 | 370,000 | $2.00 | $740.00kBuy |
| Reuven Yeganeh | Director | 2026-03-13 | 370,000 | $5.00 | $1.85MSell |
| Reuven Yeganeh | Director | 2026-03-12 | 300,000 | $5.00 | $1.50MSell |
| Reuven Yeganeh | Director | 2026-03-11 | 300,000 | $2.00 | $600.00kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Orbimed Israel Biofund GP Limited Partnership | 864.25% | 13,773,653 | $67.35M | Insider |
| Erez Chimovits | 290.33% | 4,626,978 | $22.63M | Insider |
| Chidozie Ugwumba | 188.05% | 2,997,025 | $14.66M | Insider |
| James E. Flynn | 156.50% | 2,494,108 | $12.20M | Insider |
| Takeda Pharmaceutical Co Ltd | 155.04% | 2,470,935 | $12.08M | Insider |
| Jonas Grossman | 130.53% | 2,080,217 | $10.17M | Insider |
| Fibrosis Foundation Cystic | 112.18% | 1,787,758 | $8.74M | Insider |
| Gbolahan Amusa | 16.49% | 262,871 | $1.29M | Insider |
| Kerry Propper | 16.36% | 260,771 | $1.28M | Insider |
| Deerfield Management Company LP | 8.24% | 131,270 | $641.91k | Institution |